Technical corrections only. The two versions of H.R. 4313 are substantively identical, with changes limited to the legislative status headers indicating the bill's progression from being engrossed in the House to being referred in the Senate. No substantive policy changes were made between v3 and v4.
Hospital Inpatient Services Modernization Act
- Sponsor
- Rep. Buchanan, Vern [R-FL-16]
- Committees
- Finance Committee (primary)
- Last action
- Dec 2, 2025
Bottom line
The bill extends a popular 'hospital at home' program for nearly five years while simultaneously requiring a detailed study of its effectiveness and cost, funded by a reduction in a Medicare reserve fund.
What it actually does
This bill extends the Acute Hospital Care at Home waiver flexibilities under Medicare from January 30, 2026, to September 30, 2030, allowing hospitals to continue providing acute-level care in patients' homes. It also mandates a comprehensive study by September 30, 2028, to analyze the quality, costs, and outcomes of this initiative compared to traditional inpatient care. The study is funded by a $2.5 million appropriation, offset by an equivalent reduction in the Medicare Improvement Fund.
Proponents argue
Supporters argue that extending the Acute Hospital Care at Home program allows for continued innovation in healthcare delivery, expands access to care for beneficiaries, and can potentially lower costs while improving patient experience and outcomes by providing care in a more comfortable, familiar environment. The mandated study ensures that the program's long-term viability and efficacy are thoroughly evaluated with robust data.
Opponents contend
Critics may express concerns about the quality and safety of acute care delivered outside traditional hospital settings, citing potential risks related to patient monitoring, emergency response, and caregiver burden. Some might argue that extending the waiver before the comprehensive study is complete is premature, and that the reduction in the Medicare Improvement Fund could impact other critical Medicare initiatives.
The bill is concise and can be read and understood quickly, making it accessible for a reader to evaluate its core provisions.
Section 2
Extension of Acute Hospital Care at Home Waiver Flexibilities
This section extends the period during which hospitals can operate under waivers that allow them to provide acute-level hospital care in a patient's home. The current expiration date of January 30, 2026, is changed to September 30, 2030, effectively prolonging the program for an additional four years and eight months. This allows hospitals to continue offering this alternative care model under Medicare.
Supporters argue
Supporters argue that extending these flexibilities is crucial for healthcare innovation, allowing patients to receive high-quality care in a more comfortable and potentially safer environment, reducing hospital capacity strain, and improving patient satisfaction. It builds on successful pilot programs.
Critics contend
Critics may contend that extending the program without a full, conclusive study on long-term outcomes, safety, and cost-effectiveness could pose risks to patient safety or lead to unforeseen financial burdens on the Medicare system. They might argue for more data before such a significant extension.
Tradeoffs
The provision balances the desire to continue an innovative care model that has shown promise with the need for rigorous evaluation of its long-term impacts on quality, safety, and cost.
Section 3
Mandatory Subsequent Study and Report on Acute Hospital Care at Home
This section mandates the Secretary of Health and Human Services to conduct a comprehensive study by September 30, 2028, on the Acute Hospital Care at Home initiative. The study must analyze patient selection criteria, compare quality of care (including readmissions, mortality, length of stay, infection rates), clinical conditions, hospital costs, service intensity, and socioeconomic data of patients in the home setting versus traditional inpatient care. It also requires controlling for selection bias and submitting a report to Congress.
This section reduces the Medicare Improvement Fund (MIF) by $2,500,000, changing the amount from $1,403,000,000 to $1,400,500,000.
Section 4
Why it matters:This is a standard legislative practice to provide an offset for new spending. By reducing an existing fund, the bill aims to be budget-neutral, which is often placed towards the end of a bill after the primary policy changes.
Case for: Supporters would argue that this reduction provides a fiscally responsible offset for the cost of the new study mandated in Section 3, ensuring that the bill does not increase the federal deficit. It demonstrates a commitment to pay-as-you-go budgeting.
Case against: Critics might argue that while it provides an offset, it reduces funds that could otherwise be used for other Medicare improvements or unforeseen needs, potentially impacting other beneficiaries or programs indirectly. They might view it as a budgetary maneuver rather than a true saving.
Estimated impact: This provision reduces the Medicare Improvement Fund by $2.5 million, directly offsetting the $2.5 million appropriated for the study in Section 3.